Gastrointestinal Bacteria Reference Unit, Salmonella Reference Service, Public Health England, London, NW9 5EQ, UK.
Quadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Sci Rep. 2021 Apr 5;11(1):7494. doi: 10.1038/s41598-021-86243-w.
Salmonella enterica nomenclature has evolved over the past one hundred years into a highly sophisticated naming convention based on the recognition of antigens by specific antibodies. This serotyping scheme has led to the definition of over 2500 serovars which are well understood, have standing in nomenclature and, for the majority, biological relevance. Therefore, it is highly desirable for any change in naming convention to maintain backwards compatibility with the information linked to these serovars. The routine use of whole genome sequencing and the well-established link between sequence types and serovars presents an opportunity to update the scheme by incorporating the phylogenetically relevant sequence data whilst preserving the best of serotyping nomenclature. Advantages include: overcoming the variability in antibody preparations; removing the need to use laboratory animals and implementing a truly universal system. However, the issue of trying to reproduce the phenotyping gold standard needs to be relaxed if we are to fully embrace the genomic era. We have used whole genome sequence data from over 46,000 isolates of Salmonella enterica subspecies enterica to define clusters in two stages: Multi Locus Sequence Typing followed by antigen prediction. Sequence type-serotype discrepancies were resolved using core SNP clustering to determine the phylogenetic groups and this was confirmed by overlaying the antigenic prediction onto the core SNP clusters and testing the separation of clusters using cgMLST Hierarchical Clustering. This allowed us to define any major antigenic clusters within an ST-here called the MAC type and written as ST-serovar. Using this method, 99.96% of Salmonella isolates reported in the UK were assigned a MAC type and linked to a serovar name taken from the Kauffmann and White scheme. We propose a change for reporting of Salmonella enterica sub-types using the ST followed by serovar.
肠沙门氏菌命名法在过去的一百年中发展成为一种高度复杂的命名约定,基于特定抗体对抗原的识别。这种血清型方案导致了超过 2500 种血清型的定义,这些血清型得到了很好的理解,在命名法中有其地位,并且对于大多数血清型来说,具有生物学相关性。因此,任何命名约定的改变都非常需要保持与这些血清型相关联的信息的向后兼容性。全基因组测序的常规使用以及序列类型和血清型之间的既定联系为通过纳入系统发育相关的序列数据来更新方案提供了机会,同时保留了血清型命名法的最佳部分。优点包括:克服了抗体制剂的可变性;无需使用实验动物并实施真正通用的系统。然而,如果我们要充分拥抱基因组时代,就需要放宽尝试重现表型金标准的问题。我们已经使用了超过 46000 株肠沙门氏菌亚种肠沙门氏菌的全基因组序列数据来分两个阶段定义聚类:多位点序列分型,然后是抗原预测。使用核心 SNP 聚类来解决序列型-血清型差异,以确定系统发育群,然后通过将抗原预测叠加到核心 SNP 聚类上,并使用 cgMLST 层次聚类测试聚类的分离来确认。这使我们能够在 ST 内定义任何主要的抗原簇-这里称为 MAC 型,并写成 ST-血清型。使用这种方法,英国报告的 99.96%的沙门氏菌分离株被分配了一个 MAC 型,并与从 Kauffmann 和 White 方案中选择的血清型名称相关联。我们建议使用 ST 后跟随血清型来报告肠沙门氏菌亚型。